Precision System Science Co (7707.T) Aktsia Kursus

Precision System Science Co Kursus

SULETUD
218,00
​
Turg suletud

Käive kasvas 1,8 % aastas viimase 19 aasta jooksul 5,22 B JPY-ni. Kasum aktsia kohta kasvas 7,4 % aastas viimase 17 aasta jooksul. Precision System Science Co netomarginaal on nüüd 7,6 %, tõusnud 0,6 %-lt mõni aasta tagasi. Precision System Science Co pakub praegu umbes 2,29 % dividenditootlust. Väljamaksesuhe on umbes 18 % kasumist.

Precision System Science Co aktsiahinnad

Hangi need andmed Eulerpool API kaudu

Precision System Science Co ärimudel ja aktsia analüüs

Precision System Science Co Ltd on juhtiv ettevõte meditsiinilise uurimistöö ja diagnostika valdkonnas, mis asutati Jaapanis 1989. aastal. Ettevõtte peakontor asub Chibas, Jaapanis, ning sellel on filiaalid Euroopas, USA-s ja Aasias. Ettevõtte ärimudel keskendub laia valiku instrumentide, seadmete ja teenuste pakkumisele meditsiinitööstuse jaoks teadusuuringute, diagnostika ja ravi eesmärgil. Ettevõte disainib ja toodab oma tooteid ning pakub ka kohandatud lahendusi klientidele. See on jagatud erinevateks osakondadeks, sealhulgas molekulaarbioloogia ja diagnostika instrumentide ning seadmete, raku analüüsi, mikroskoopia ja proovide ettevalmistuse osakondadeks. Nad pakuvad tooteid nagu PCR-süsteemid, qPCR-süsteemid, automaatsed proovide ettevalmistamise süsteemid ja RNA eraldamiskitid molekulaarbioloogia ja diagnostika jaoks. Nad toodavad ka rakulugemis-süsteeme, flow tsütomeetreid, kiiret kujutamissüsteeme ja mitmeaugulistega plaadi lugejaid raku analüüsiks. Mikroskoopia osakonnas toodab ettevõte kvaliteetseid fluorestsents-mikroskoobe ja dekonvolutsioon-mikroskoobe valkude ja DNA molekulide analüüsiks, haiguste diagnoosimiseks, ravimite arendamiseks jne. Proovide ettevalmistamise osakonnas toodavad nad automaatseid jaamu, mida kasutatakse genoomika ja proteoomika analüüsiks mõeldud proovide ettevalmistamiseks. Ettevõte tegeleb ka meditsiiniseadmete ja -instrumentide uurimise ja arendamisega, et parandada meditsiinilise diagnostika ja ravi kvaliteeti. Eduka toote näiteks on qPCR termotsükler MIQE, mida kasutatakse selliste haiguste nagu vähk diagnoosimisel ja ravis. Precision System Science Co Ltd on mänginud olulist rolli COVID-19 pandeemia tõrjumisel, tootes diagnoosimiseks testikomplekte ja pakkudes arenenud PCR-süsteeme massitestideks. Nad on pühendunud pidevale innovatsioonile ja oma toodete ning teenuste täiustamisele, et rahuldada muutuvaid meditsiinitööstuse vajadusi. Oma tugeva esinemise ja pühendumusega tipptasemel ja innovaatiliste toodete ning teenuste pakkumisele jäävad nad oluliseks mängijaks globaalsel meditsiiniseadmete ja -instrumentide turul.

Korduma kippuvad küsimused Precision System Science Co aktsia kohta

The business model of Precision System Science Co Ltd is focused on providing innovative solutions in the field of life science research and diagnostics. The company specializes in developing and manufacturing advanced instruments, equipment, and consumables for genetic testing, nucleic acid purification, and molecular biology applications. Precision System Science Co Ltd aims to contribute to scientific advancements and improve healthcare outcomes through its cutting-edge technologies and products. The company's commitment to continuous innovation and high-quality solutions has made it a leading player in the industry.

Precision System Science Co Ltd is primarily active in the life sciences and healthcare industries.

The main competitors of Precision System Science Co Ltd in the market are companies like Thermo Fisher Scientific Inc., Beckman Coulter, Inc., and Roche Diagnostics.

Precision System Science Co Ltd (PSS) is a renowned company in the field of life sciences and biotechnology. Established in 1986, PSS has since been dedicated to developing innovative solutions and high-quality products for the life sciences industry. With its headquarters in Japan, PSS has expanded globally, with subsidiaries and distributors across various countries. The company focuses on providing advanced technologies, including PCR instruments, nucleic acid extraction systems, automated liquid handling systems, and more. PSS's commitment to research and development has led to breakthroughs in molecular biology, diagnostics, and genomics. Today, Precision System Science Co Ltd continues to be a leading force driving advancements in the life sciences sector.

Precision System Science Co Ltd has achieved several significant milestones. It has successfully established itself as a key player in the life science industry, offering innovative solutions and products. The company has made remarkable progress in the field of genomic research and development, contributing to advancements in precision medicine. Precision System Science Co Ltd has also achieved commendable success with its automated laboratory equipment, revolutionizing the efficiency and accuracy of scientific experiments. Furthermore, the company has expanded its global presence, forging strategic partnerships and collaborations with renowned institutions and multinational corporations. These accomplishments demonstrate Precision System Science Co Ltd's commitment to technological excellence and its position as a leader in the industry.

Precision System Science Co Ltd is primarily present in Japan.

Precision System Science Co Ltd (PSS) is a leading company in the field of life sciences and diagnostics. Their values revolve around innovation, quality, and customer satisfaction. PSS is committed to providing reliable and cutting-edge solutions that meet the evolving needs of the scientific community. With a corporate philosophy centered on integrity and transparency, PSS strives to contribute to society through advancements in healthcare and research. By continuously investing in research and development, PSS aims to deliver state-of-the-art technologies and services that empower their customers to achieve breakthroughs in their respective fields.

7 analüütikut hindavad praegu Precision System Science Co aktsiat: 0 soovitab osta, 3 hoida ja 4 müüa.

Praeguse kursiga kaubeldakse Precision System Science Co aktsiaga 1,23 EUR (218,00 JPY) juures.

Precision System Science Co Ltd (PSS) is a Japanese company specializing in the development, manufacturing, and distribution of systems for molecular biology research and diagnostics. The company's business model includes several divisions, including consumables, instruments, services, and licensed products. In the consumables division, PSS offers a wide range of items needed for conducting molecular biology experiments. These include products such as PCR reagents, DNA extraction kits, probes and primers, electrophoresis kits, antibodies and proteins, cell culture media, and plate systems. PSS aims to provide highly effective technologies and reagents at every step of DNA analysis and manipulation to ensure precision and reproducibility of research results. In the instruments division, PSS offers automated systems that facilitate the work of laboratory personnel. Products include pipettors, thermocyclers, sample preparation stations, and cell manipulators. These instruments improve workflows and reduce human errors, resulting in higher efficiency and accuracy in experiment execution. PSS has gained recognition in the field of automated systems through the development of innovative high-throughput systems and analytical platforms. PSS also offers a variety of services, including customer support, training, repairs, and validation services. Through its extensive services, PSS ensures that customer performance is enhanced through highly efficient and reliable processes. Licensing of technologies and products is also an important component of PSS's business model. The company collaborates closely with companies and institutions to commercialize their technologies and distribute their products globally. PSS focuses on the development of products and technologies that align with the needs and advancements in molecular biology research and diagnostics. The company has established itself as a pioneer in the field of DNA manipulation and analysis, underscored by a strong research and development department. PSS's products are used by scientists and researchers worldwide to make groundbreaking discoveries and advance knowledge in biological science. Overall, PSS aims to strengthen and expand its market position by creating an increasingly diverse product range and a stronger presence in the global market. The company is committed to understanding and meeting customer needs in order to develop ever more innovative products and technologies. PSS is a company focused on promoting scientific knowledge and advancements worldwide while always keeping its environmental and societal responsibilities in mind.

Precision System Science Co käive on 5,22 B JPY. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.

Precision System Science Co kasum on 394,87 M JPY. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.

Võrdlusarvud hinna ja kasumiga (P/E) Precision System Science Co jaoks on praegu 15,13. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Precision System Science Co aktsia väärtust.

Kursuse ja müügimahu suhe (P/S) Precision System Science Co jaoks on praegu 1,15. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Precision System Science Co aktsia jaoks.

Eulpooli kvaliteedinäitaja Precision System Science Co jaoks on 3/10.

Precision System Science Co ISIN on JP3833400009. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.

Precision System Science Co ticker on 7707.T. Ticker-sümbol kasutatakse Precision System Science Co aktsiate kauplemiseks börsil.

Õiglane väärtusTerminal
191,84 JPY
Üle-/alahinnangTerminal
Õiglaselt hinnatakse
Tööstus
Eluteaduste tööriistad ja teenused
Aktsiate arv
Töötajad
Tulu töötaja kohta
31,43 M JPY
Tulukasvu keskmine 5 aastat
EBIT kasvu keskmine 5 aastat
Puhaskasumi kasvu keskmine 5 aastat
Veebisait pss.co.jp
Valuuta
JPY
Börsi noteerimise algus
1. veebr 2001
ISIN
JP3833400009
CUSIP
J6397V109
SEDOL
6318246
Turukapitalisatsioon
5,99 B JPYMid Cap
52-nädala vahemik
PEG
—
P/E suhe
P/E e 2027
—
P/S
P/S e
—
EV/EBIT
28,08
P/B suhe
1,47
ROE (omakapitali tootlus)
ROA (varatootlus)
ROCE (kasutatud kapitali tootlus)
ROIC (investeeritud kapitali tootlus)
7,72 %
Viimati värskendatud 13. okt 2026, 09:37

Precision System Science Co FIGI

7707:JP · BBG000F6HFK57707:JT · BBG000F6HG327707:JJ · BBG000F6HNF47707:JE · BBG000F6HQP67707:JI · BBG000F6HR29PCNEF:US · BBG000GPV458PCNEF:PQ · BBG002J8Z197PCNEF:UV · BBG002J8Z1C37707:JU · BBG002QKC0H07707:JW · BBG00875H3C57707:JV · BBG0193R9BF6